Kidney function as a predictor of noncardiovascular mortality.
暂无分享,去创建一个
P. Chaves | D. Siscovick | A. Newman | M. Shlipak | M. Sarnak | R. Katz | L. Fried | C. Stehman-Breen | D. Gillen | C. Hirsch | N. Jenny | A. Bleyer | A. Newman
[1] A. Christensson,et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. , 2005, Clinical chemistry.
[2] D. Siscovick,et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.
[3] L. Fried,et al. Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults , 2005, Annals of Internal Medicine.
[4] J. Björk,et al. A cystatin C‐based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft‐Gault formula , 2005, Scandinavian journal of clinical and laboratory investigation.
[5] G. Filler,et al. Cystatin C as a marker of GFR--history, indications, and future research. , 2005, Clinical biochemistry.
[6] M. Thun,et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. , 2004, American journal of epidemiology.
[7] Deeb N Salem,et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.
[8] Bruce M Psaty,et al. The presence of frailty in elderly persons with chronic renal insufficiency. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] D. Spiegelman,et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. , 2004, Kidney international.
[10] B. Astor,et al. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease , 2004, Current opinion in nephrology and hypertension.
[11] M. D'Amico,et al. Ill-defined and multiple causes on death certificates – A study of misclassification in mortality statistics , 1999, European Journal of Epidemiology.
[12] R. Kronmal,et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. , 2003, Journal of the American College of Cardiology.
[13] P. Whelton,et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. , 2003, Journal of the American Society of Nephrology : JASN.
[14] B. Psaty,et al. Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency , 2003, Circulation.
[15] B. Psaty,et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. , 2002, Kidney international.
[16] V. Dharnidharka,et al. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] R. Poveda,et al. Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] K Doqi,et al. clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .
[20] R. Bilous,et al. Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. , 2002, Diabetes care.
[21] Kdoqi Disclaimer. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] A. Nissenson,et al. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. , 2001, Journal of the American Society of Nephrology : JASN.
[23] D. Fliser,et al. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] A. Darnell,et al. Literature Abstracts , 2000, Pediatric Nephrology.
[25] S. Birkeland,et al. Cancer risk in patients on dialysis and after renal transplantation , 2000, The Lancet.
[26] P. Nilsson-ehle,et al. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. , 1999, Scandinavian journal of clinical and laboratory investigation.
[27] R. de Marco,et al. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. , 1999, Diabetes care.
[28] E. Randers,et al. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. , 1999, Scandinavian journal of clinical and laboratory investigation.
[29] J. Coresh,et al. Epidemiology of cardiovascular risk factors in chronic renal disease. , 1998, Journal of the American Society of Nephrology : JASN.
[30] M. Harris,et al. Mortality in Adults With and Without Diabetes in a National Cohort of the U.S. Population, 1971–1993 , 1998, Diabetes Care.
[31] R. Tracy,et al. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.
[32] S D Stellman,et al. Accuracy of death certificate completion: the need for formalized physician training. , 1996, JAMA.
[33] L. Kuller,et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.
[34] L H Kuller,et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.
[35] M. Cushman,et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.
[36] K. Iseki,et al. Evidence for increased cancer deaths in chronic dialysis patients. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] R. Kronmal,et al. Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular health study. , 1993, The American review of respiratory disease.
[38] B M Psaty,et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1991, Stroke.
[39] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[40] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[41] H. Chui,et al. The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.
[42] A S Leon,et al. A questionnaire for the assessment of leisure time physical activities. , 1978, Journal of chronic diseases.